File Download
  Patent History
  • Application
    US 10/836390 2004-04-29
  • Publication
    US 2005244839 2005-11-03
Supplementary

published patent: Granulin-epithelin precursor (GEP) overexpression as a target for diagnosis, prognosis and treatment of hepatocellular carcinoma (HCC)

TitleGranulin-epithelin precursor (GEP) overexpression as a target for diagnosis, prognosis and treatment of hepatocellular carcinoma (HCC)
Priority Date2004-04-29 US 10/836390
Inventors
Issue Date2005
Citation
US Published patent application US 2005244839. Washington, DC: US Patent and Trademark Office (USPTO), 2005 How to Cite?
AbstractThis invention further provides methods for determining whether an agent causes a reduction in the activity of a Granulin-Epithelin Precursor (GEP) protein in a cell. This invention also provides methods for reducing the expression of Granulin-Epithelin Precursor (GEP) protein in a cell. This invention also provides methods for determining whether a subject is afflicted with Hepatocellular carcinoma (HCC). This invention provides methods for determining whether a subject is afflicted with Hepatocellular carcinoma (HCC) This invention further provides a method for treating a subject afflicted with Hepatocellular carcinoma (HCC) comprising administering to the subject a therapeutically effective amount of an agent which specifically interferes with the expression of the Granulin-Epithelin Precursor (GEP) protein in the tumor cells of the subject.
Persistent Identifierhttp://hdl.handle.net/10722/176910

 

DC FieldValueLanguage
dc.date.accessioned2012-11-30T08:38:43Z-
dc.date.available2012-11-30T08:38:43Z-
dc.date.issued2005-
dc.identifier.citationUS Published patent application US 2005244839. Washington, DC: US Patent and Trademark Office (USPTO), 2005en_HK
dc.identifier.urihttp://hdl.handle.net/10722/176910-
dc.description.abstractThis invention further provides methods for determining whether an agent causes a reduction in the activity of a Granulin-Epithelin Precursor (GEP) protein in a cell. This invention also provides methods for reducing the expression of Granulin-Epithelin Precursor (GEP) protein in a cell. This invention also provides methods for determining whether a subject is afflicted with Hepatocellular carcinoma (HCC). This invention provides methods for determining whether a subject is afflicted with Hepatocellular carcinoma (HCC) This invention further provides a method for treating a subject afflicted with Hepatocellular carcinoma (HCC) comprising administering to the subject a therapeutically effective amount of an agent which specifically interferes with the expression of the Granulin-Epithelin Precursor (GEP) protein in the tumor cells of the subject.en_HK
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License For Public Patent Documentsen_US
dc.titleGranulin-epithelin precursor (GEP) overexpression as a target for diagnosis, prognosis and treatment of hepatocellular carcinoma (HCC)en_HK
dc.typePatenten_US
dc.description.naturepublished_or_final_versionen_US
dc.identifier.hkuros92357-
dc.contributor.inventorCheung, STen_HK
dc.contributor.inventorFan, STen_HK
patents.identifier.applicationUS 10/836390en_HK
patents.description.countryUnited States of Americaen_HK
patents.date.publication2005-11-03en_HK
patents.date.application2004-04-29en_HK
patents.date.priority2004-04-29 US 10/836390en_HK
patents.description.ccUSen_HK
patents.identifier.publicationUS 2005244839en_HK
patents.relation.familyCN 1950521 (A) 2007-04-18en_HK
patents.relation.familyCN 101553728 (A) 2009-10-07en_HK
patents.relation.familyUS 2005244839 (A1) 2005-11-03en_HK
patents.relation.familyUS 2008199470 (A1) 2008-08-21en_HK
patents.relation.familyWO 2005106019 (A1) 2005-11-10en_HK
patents.relation.familyWO 2008064570 (A1) 2008-06-05en_HK
patents.description.kindA1en_HK
patents.typePatent_publisheden_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats